Endocrinology

Showing folder Endocrinology

Resources65

Page 2 of 3

Clinical reviewsDIABETES MELLITUS: FROM MOLECULAR MECHANISM TO PATHOPHYSIOLOGY AND PHARMACOLOGYOluwafemi Adeleke Ojo, Hannah Sokolayam Ibrahim, Damilare Emmanuel Rotimi, Akingbolabo Daniel Ogunlakin, Adebola Busola Ojo·Endocrinology· 2023· 30 pages

Clinical reviewsTYPE 1 DIABETESLaura M. Jacobsen, MD; Desmond A. Schatz, MD·Endocrinology· 14 pages

Clinical reviewsACROMEGALY: PATHOGENESIS, DIAGNOSIS, AND MANAGEMENTHealth & Science University, Portland, OR, USA·Endocrinology· 2022· 23 pages

Clinical reviewsGLP-1 RECEPTOR AGONISTSMassachusetts Medical Society·Endocrinology· 2026· 12 pages

Clinical reviewsTHE INCIDENCE AND RISK FACTORS OF URINARY TRACT INFECTION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS USING SGLT2 INHIBITORS: A REAL-WORLD OBSERVATIONAL STUDYDepartment of Pharmaceutical Care, Walailak University, Tha Sala, Nakhon Si Thammarat, Thailand·Endocrinology· 9 pages

Clinical reviewsADRENAL FAILURE: AN EVIDENCE-BASED DIAGNOSTIC APPROACHKGN Diabetes and Endocrine Centre, JSS Medical College, Saifee Hospital, Lancashire Teaching Hospitals NHS Trust, The University of Manchester·Endocrinology· 12 pages

Clinical reviewsHYPOTHYROIDISM: A REVIEWLayal Chaker, MD, MPH, PhD; Maria Papaleontiou, MD·Endocrinology· 11 pages

Clinical reviewsGASTROINTESTINAL ADVERSE EFFECTSEndocrinology· 12 pages

Clinical reviewsOSTEOPOROSISCarrie Ye, Peter Ebeling, Gregory Kline·Endocrinology· 2025· 14 pages

1

Clinical reviewsCOMBINING GLUCAGON - LIKE PEPTIDE - 1 RECEPTOR AGONISTS (GLP - 1RAS) AND SODIUM - GLUCOSE COTRANSPORTER - 2 INHIBITORS (SGLT2IS) IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)Pierre Gourdy, Patrice Darmon, François Dievart, Jean‑Michel Halimi, Bruno Guerci·Endocrinology· 2023· 14 pages

Clinical reviewsOPIOID-INDUCED ADRENAL INSUFFICIENCY: DIAGNOSIS AND MANAGEMENTMayo Clinic, Rochester, MN, USA·Endocrinology· 2026· 9 pages

Clinical reviewsDEINSULINISATION IN TYPE 2 DIABETES: EVIDENCE-BASED STRATEGIES FOR SAFETREATMENT SIMPLIFICATIONCarlo B Giorda, Valentina Anelli, Umberto Goglia, Stefano De Riu, Giuseppina Russo, Marco Gallo, Salvatore De Cosmo, Gerardo Corigliano, Michele Roberto Modestino·Endocrinology· 8 pages

Clinical reviewsDISCONTINUATION OF LEVOTHYROXINE IN ADULTS AGED 60 YEARS OR OLDERJanneke Ravensberg, MD; Jacobijn Gussekloo, MD, PhD; Saskia Le Cessie, PhD; Olaf M. Dekkers, MD, PhD; Simon P. Mooijaart, MD, PhD; Rosalinde K. E. Poortvliet, MD, PhD·Endocrinology· 2024· 8 pages

Clinical reviewsGLICLAZIDE IN TYPE 2 DIABETES: COST-EFFECTIVE AND CLINICALLY RELEVANT IN RESOURCE-LIMITED SETTINGSDr. Reddy·Endocrinology· 2 pages

Clinical reviewsTIRZEPATIDE VERSUS INTENSIFIED CONVENTIONAL CARE AFTER 2 YEARS OF TREATMENT IN EARLY TYPE 2 DIABETESStefano Del Prato, MD; Robert J. Heine, MD; Federico C. Pérez Manghi, MD; Stanley H. Hsia, MD; Elisa Gomez-Valderas, MS; Meltem Zeytinoglu, MD; Elisa Razzoli, MD; Jacek Kiljanski, MD; Palash Sharma, PhD; Alastair Knights, PhD; Vivian Thuyanh Thieu, PhD·Endocrinology· 13 pages

Clinical reviewsMANAGEMENT OF THYROID NODULESErik K Alexander, Gerard M Doherty, Justine A Barletta·Endocrinology· 2022· 9 pages

Clinical reviewsA WHOLE-FOOD, PLANT-BASED INTENSIVE LIFESTYLE INTERVENTION IMPROVES GLYCAEMIC CONTROL AND REDUCES MEDICATIONS IN INDIVIDUALS WITH TYPE 2 DIABETES: A RANDOMISED CONTROLLED TRIALDepartment of Nutrition Sciences, University of Alabama at Birmingham; Brenda Davis Nutrition Consultation Services; School of Public Health, Center for Nutrition, Lifestyle, and Disease Prevention, Loma Linda University; Department of Preventive·Endocrinology· 2024· 12 pages

Clinical reviewsROLE OF INCRETIN-BASED THERAPY IN HOSPITALIZED PATIENTS WITH TYPE 2 DIABETESDepartment of Internal Medicine, Specialities Hospital, National Medical Center 'La Raza', Instituto Mexicano del Seguro Social, Mexico City, Mexico·Endocrinology· 2 pages

Clinical reviewsHYPERCALCEMIA: A REVIEWMarcella Donovan Walker, MD; Elizabeth Shane, MD·Endocrinology· 2022· 13 pages

Clinical reviewsFROM ADIPOSITY TO MULTISYSTEM MORBIDITY: THE CASE FOR WEIGHT LOSS AS DISEASE MODIFICATIONSchool of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK·Endocrinology· 18 pages

Clinical reviewsVITAMIN D DEFICIENCYHarold N Rosen, MD·Endocrinology· 2025· 29 pages

Clinical reviewsDIABETIC PERIPHERAL NEUROPATHY AND ASSOCIATED FACTORS AMONG PATIENTS ATTENDING MBARARA REGIONAL REFERRAL HOSPITAL, SOUTHWESTERN UGANDA: A CROSS-SECTIONAL STUDYMbarara Regional Referral Hospital·Endocrinology· 2025· 10 pages

Clinical reviewsRISK PREDICTION IN PATIENTS WITH DIABETES: IS SCORE 2D THE PERFECT SOLUTION?Karolinska University Hospital, Munich Helmholtz Center·Endocrinology· 2023· 3 pages

Clinical reviewsEFFECTS OF RELOCATION OF SEDENTARY TIME AND PHYSICAL ACTIVITY IN OLDER ADULTS WITH DIABETES MELLITUSUniversidade Federal do Triângulo Mineiro, Universidade do Estado da Bahia·Endocrinology· 2023· 7 pages

PreviousPage 2 of 3Next